letrozole100mg HY-14248 and 2 more items

The University of Virginia awarded contract A207_PO-0347893-V3 to Medchemexpress LLC on October 10, 2026, for the procurement of pharmaceutical products. The contract encompasses three distinct pharmaceutical line items: Fulvestrant (10 milligrams) in a quantity of 60 units, Letrozole (100 milligrams) in a quantity of 79 units, and Palbociclib Isethionate (10 milligrams) in a quantity of 84 units. All line items are priced at one dollar per unit and are to be delivered to the buyer. The cumulative contract value is two hundred twenty-three dollars.

This Virginia-based procurement is classified as contract number A207_PO-0347893-V3. The pharmaceutical products supplied represent specialty oncology medications commonly utilized in cancer treatment protocols. The delivery location is specified as the buyer's facility, consistent with standard University of Virginia procurement practices. The contract reflects a focused acquisition of research or clinical-grade pharmaceutical materials with a defined scope limited to the three identified line items.